This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Yellowbrick has established a clinical philosophy and treatment model, which integrates psycho-neurobiology, developmental psychology and in-depth psychotherapy.
Psycho-neurobiology focuses on the process of relationships and subsequent development of self-regulation functions. These experiences affect the structural patterning within the brain throughout life. These patterns become organizers for basic survival functions such as the experience of safety, attachment patterns and the capacity to manage emotional life with a balance of initiative, risk assessment and restraint.
Yellowbrick recognizes and addresses the unique challenges of the emerging adult population through programs that emphasize multi-specialty evaluation, therapeutic residences, research-based strategies and life-skills interventions.
Building upon the psycho-neurobiological foundation, Yellowbrick provides relationships, treatment services including Deep TMS therapy, and involvement in the community with an emphasis on the following challenges:
Authentic empowerment and intention; identity consolidation
Honest and explicit communication
Effective self-regulation of emotions such as impulsivity, disengagement and the connections of emotional life into the body
Relationship patterns and difficulties with closeness
Self-affirming and fulfilling relationships
Negotiation of developmental transition with family
Life skills competence
Capacity to pursue realistic ambitions, education and career development
Please fill all the marked fields